Mometasone Furoate Ointment
Product Images NDC 21922-071

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Mometasone Furoate (NDC 21922-071). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Encube Ethicals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton1 (Carton1)

Mometasone Furoate Ointment USP 0.1% topical ointment packaging label by Encube Ethicals, Inc. The label includes the product name, strength (0.1%), dosage form (ointment), net weight (15 g), and manufacturer details (Encube Ethicals Pvt. Ltd., India). It also states use for dermatologic purposes only and not for ophthalmic use, with Rx only designation.*

FDA Label Image

Carton2 (Carton2)

Mometasone Furoate Ointment USP, 0.1% topical ointment in a 45 g package by Encube Ethicals, Inc. The label states it is for dermatologic use only, not for ophthalmic use, and is Rx only. Manufactured by Encube Ethicals Pvt. Ltd. in India and distributed by Encube Ethicals, Inc. in the USA. Active ingredient strength is 0.1% mometasone furoate.*

FDA Label Image

Structure (Structure)

Chemical structure of Mometasone furoate, showing its molecular composition including chlorine, oxygen, carbon, and hydrogen atoms arranged in a corticosteroid framework with characteristic rings and functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.